Results 201 to 210 of about 113,722 (335)

Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR) [PDF]

open access: green, 2007
Jeremiah Stitham   +5 more
openalex   +1 more source

Artificial intelligence streamlines scientific discovery of drug–target interactions

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Drug discovery is a complicated process through which new therapeutics are identified to prevent and treat specific diseases. Identification of drug–target interactions (DTIs) stands as a pivotal aspect within the realm of drug discovery and development. The traditional process of drug discovery, especially identification of DTIs, is marked by
Yuxin Yang, Feixiong Cheng
wiley   +1 more source

BRET analysis of GPCR oligomerization: newer does not mean better

open access: green, 2006
Michel Bouvier   +4 more
openalex   +2 more sources

Contributions of synaptic energetic dysfunction by microtubule dynamics and microtubule‐based mitochondrial transport disorder to morphine tolerance

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Morphine is among the most powerful analgesic, but its long‐term use can cause tolerance. Synaptic ATP supply is critical for maintaining synaptic transmission. Microtubule‐based mitochondrial transport ensures synaptic energy supply.
Zheng Li   +9 more
wiley   +1 more source

Genome-wide pan-GPCR cell libraries accelerate drug discovery

open access: yesActa Pharmaceutica Sinica B
G protein-coupled receptors (GPCRs) are pivotal in mediating diverse physiological and pathological processes, rendering them promising targets for drug discovery.
Hanting Yang   +12 more
doaj  

The cell biology of Smo signalling and its relationships with GPCRs

open access: bronze, 2006
Ana Ruiz‐Gómez   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy